MedPath

Hemodynamics and Vital Organ Function in Intracerebral Hemorrhage

Not Applicable
Conditions
Balanced Anesthesia
Intracerebral Hemorrhage
Total Intravenous Anesthesia
Interventions
Drug: Balanced anesthesia group
Drug: Total intravenous anesthesia group
Registration Number
NCT03129009
Lead Sponsor
Xuzhou Medical University
Brief Summary

Spontaneous non-traumatic intracerebral hemorrhage (ICH) is a common symptom in clinical practice and is the most serious among all types of stroke.Recently, as a relatively mainstream and recognized INTERACT2 (five well-known international studies in the cerebrovascular field: IMS-III, MR RESCUE, SYNTHESIS EXPANSION, INTERACT2, CHANCE) studies have shown that in patients with standard systolic blood pressure Early intensive antihypertensive therapy does not increase the incidence of death or serious adverse events. The above studies confirm the safety and efficacy of early potent depression.In 2017, Anesthesiology published a META analysis of intraoperative hypotension and blood pressure versus baseline fluctuations. The final outcome showed that 20% of blood pressure in the study was similar to MAP \<65 mmHg, regardless of the duration of the duration There will be postoperative myocardial and renal damage. Ischemia is a very important cause of organ damage. Myocardial injury is closely related to the level of mean arterial pressure, while ischemia and ischemic reperfusion injury are closely related to postoperative acute renal injury.There is no targeted guideline for ICH perioperative blood pressure management, especially intraoperative blood pressure management, and no previous studies have studied most of the studies involving ICH patients with conservative treatment, ICH patients with surgical treatment There are few reports on blood pressure control during surgery.

Detailed Description

The general anesthesia used in craniotomy, whether intravenous anesthesia or total intravenous anesthesia, have a certain degree of blood pressure and lead to a decline in blood pressure, the study aims to spontaneous cerebral hemorrhage this special And to observe the changes of hemodynamics and the changes of heart and kidney function in ICH, and to explore the relationship between the anesthesia and the blood of ICH. The range of volatility.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
90
Inclusion Criteria
  1. Age 18 years to90 years.
  2. acute stroke symptoms caused by initial spontaneous intracerebral hemorrhage as determined by CT or MRI Blood: the screen area: 30-50ml; cerebellum parts:> 10ml.
  3. GCS score> 5 points
Exclusion Criteria
  1. ICH is caused by other factors (anticoagulation associated with cerebral hemorrhage, arteriovenous malformations, tumors)
  2. intracerebral hematoma is thought to be associated with trauma (simple intracerebral hemorrhage)
  3. there are surgical contraindications.
  4. history of ischemic stroke
  5. acute spontaneous intracerebral hemorrhage before the presence of dementia or limb dysfunction (paralysis or aphasia.
  6. preoperative combined with chronic kidney disease (standard for glomerular filtration rate below 60 ml · min-1 · 1.73 m2 or received dialysis).
  7. anesthesia time shorter than 60 min or lack of relevant basic information.
  8. while there is interference with the experimental results or follow-up of the disease (tumor, severe cardiovascular disease).

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Balanced anesthesia groupBalanced anesthesia groupBalanced anesthesia induced with sufentanil,etomidate,cisatracurium and midazolam and maintained with cisatracurium and remifentanil target controlled infusion and sevoflurane inhalation
Total intravenous anesthesia groupTotal intravenous anesthesia groupTotal intravenous anesthesia induced with sufentanil,etomidate,cisatracurium and midazolam and maintained with propofol,cisatracurium and remifentanil target controlled infusion
Primary Outcome Measures
NameTimeMethod
MAP changes relative to the changes before inductionIntraoperative

MAP changes relative to the changes before induction; \<20%, 20% -30%, 30% -40%,\> 40%MAP changes relative to the changes before induction; \<20%, 20% -30%, 30% -40%,\> 40%

Secondary Outcome Measures
NameTimeMethod
Acute renal failure7 days post surgery

Increased absolute serum creatinine ≥0.3mg / dl (≥26.5μmol / l), or ≥50% increase (1.5 times the baseline), or urine \<0.5ml / (kg.h) for more than 6 hours Obstructive nephropathy or dehydration status)

Troponin T6 hour, 12 hour, 24 hour, 48 hour post surgery

The levels of troponin T were released before anesthesia induction at 6 hour, 12 hour, 24 hour and 48 hour

CK-MB release level6 hour, 12 hour,24 hour,48 hour post surgery

Clinically, CK-MB more than the total activity of CK 3 (ion exchange column chromatography) or 10 (immunosuppressive method) as the basis for the diagnosis of acute myocardial infarction.

Serum creatinine24 hour, 48 hour,72 hour post surgery

Serum creatinine levels were measured before and after anesthesia induction at 24 hour, 48 hour

All-cause mortality7 days post surgery

All-cause mortality is the ratio of the total number of deaths resulting from a variety of causes over a period of time to the average population of the population over the same period.

Trial Locations

Locations (1)

The Affiliated Hospital of Xuzhou Medical University

🇨🇳

Xuzhou, Jiangsu, China

© Copyright 2025. All Rights Reserved by MedPath